Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
-
2023 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Diagnostik und Therapie der exogen-allergischen Alveolitis : S2k-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. und der Deutschen Gesellschaft für Allergologie und klinische Immunologie e. V.In: Pneumologie (2024) in pressOnline Volltext: dx.doi.org/
-
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses : S2k Guideline of the German Respiratory SocietyIn: Respiration: International Journal of Thoracic Medicine (2024) 540856 in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses : S2k Guideline of the German Respiratory SocietyIn: Respiration: International Journal of Thoracic Medicine (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
COVID-19 in patients with pulmonary alveolar proteinosis : A European multicentre studyIn: ERJ Open Research Jg. 9 (2023) Nr. 1, 00199-2022Online Volltext: dx.doi.org/ (Open Access)
-
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis : Post-Hoc Analysis of Six Clinical StudiesIn: Advances in Therapy Jg. 40 (2023) Nr. 9, S. 3937 - 3955Online Volltext: dx.doi.org/ (Open Access)
-
Erratum : Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler FibrosenIn: Pneumologie Jg. 77 (2023) Nr. 2, S. e1Online Volltext: dx.doi.org/
-
GLPG1205 for idiopathic pulmonary fibrosis : A phase 2 randomised placebo-controlled trialIn: European Respiratory Journal (ERJ) Jg. 61 (2023) Nr. 3, 2201794Online Volltext: dx.doi.org/ (Open Access)
-
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare VariantsIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 207 (2023) Nr. 9, S. 1194 - 1202Online Volltext: dx.doi.org/
-
Imbalanced distribution of regulatory T cells and Th17.1 cells in the peripheral blood and BALF of sarcoidosis patients : Relationship to disease activity and the fibrotic radiographic phenotypeIn: Frontiers in Immunology Jg. 14 (2023) 1185443Online Volltext: dx.doi.org/ (Open Access)
-
Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen : S2k-Leitline der Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V.In: Pneumologie Jg. 77 (2023) Nr. 2, S. 94 - 119Online Volltext: dx.doi.org/
-
S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im ErwachsenenalterIn: Pneumologie Jg. 77 (2023) Nr. 5, S. 269 - 302Online Volltext: dx.doi.org/ (Open Access)
-
Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung DiseaseIn: Journal of Clinical Medicine (JCM) Jg. 12 (2023) Nr. 3, 1173Online Volltext: dx.doi.org/ (Open Access)
-
Thoracic pain in patients with chronic interstitial lung disease : an underestimated symptomIn: Frontiers in Medicine Jg. 10 (2023) 1147555Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical TrialsIn: JAMA: Journal of the American Medical Association Jg. 329 (2023) Nr. 18, S. 1567 - 1578Online Volltext: dx.doi.org/
-
A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial PneumoniaIn: Pneumologie Jg. 76 (2022) Nr. 01, S. 25 - 34Online Volltext: dx.doi.org/ (Open Access)
-
A transcriptomics-based meta-analysis identifies a cross-tissue signature for sarcoidosisIn: Frontiers in Medicine Jg. 9 (2022) 960266Online Volltext: dx.doi.org/ (Open Access)
-
Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of SarcoidosisIn: Lung Jg. 200 (2022) Nr. 5, S. 633 - 641Online Volltext: dx.doi.org/ (Open Access)
-
Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic TherapyIn: Case Reports in Pulmonology Jg. 2022 (2022) 4054339Online Volltext: dx.doi.org/ (Open Access)
-
IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung diseaseIn: Immunobiology Jg. 227 (2022) Nr. 5, 152258Online Volltext: dx.doi.org/
-
Nanotechnology-facilitated vaccine development during the coronavirus disease 2019 (COVID-19) pandemicIn: Exploration Jg. 2 (2022) Nr. 5, 20210082Online Volltext: dx.doi.org/ (Open Access)
-
Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases : Data from the randomized controlled INBUILD trialIn: Respiratory Research Jg. 23 (2022) Nr. 1, 85Online Volltext: dx.doi.org/ (Open Access)
-
Transbronchial cryobiopsy : the right procedure for the right patient in the right place at the right timeIn: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. 5, 2201648Online Volltext: dx.doi.org/
-
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?In: Therapeutic Advances in Musculoskeletal Disease Jg. 13 (2021) S. 1 - 21Online Volltext: dx.doi.org/ (Open Access)
-
Bronchoscopic performance of bronchoalveolar lavage in Germany - A call for standardizationIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 38 (2021) Nr. 1,Online Volltext: dx.doi.org/
-
Immunohistochemical Detection of Potential Microbial Antigens in Granulomas in the Diagnosis of SarcoidosisIn: Journal of Clinical Medicine (JCM) Jg. 10 (2021) Nr. 5, 983Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Misconceptions regarding symptoms of sarcoidosisIn: The Lancet Respiratory Medicine Jg. 9 (2021) Nr. 8, S. 816 - 818Online Volltext: dx.doi.org/
-
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosisIn: European Respiratory Journal (ERJ) Jg. 57 (2021) Nr. 2, S. 1902442Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF) : A double-blind, randomised, placebo-controlled, phase 2b trialIn: The Lancet Respiratory Medicine Jg. 9 (2021) Nr. 5, S. 476 - 486Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPFIn: Orphanet Journal of Rare Diseases Jg. 16 (2021) Nr. 1, 111Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
S2K Guideline for Diagnosis of Idiopathic Pulmonary FibrosisIn: Respiration: International Journal of Thoracic Medicine Jg. 100 (2021) Nr. 3, S. 238 - 271Online Volltext: dx.doi.org/ (Open Access)
-
Sprachliche Validierung des Fibrose-Fragebogens zur Erfassung der Lebensqualität bei Patienten mit idiopathischer Lungenfibrose und idiopathischer nichtspezifischer interstitieller PneumonieIn: Pneumologie Jg. 75 (2021) Nr. 10, S. 753 - 760Online Volltext: dx.doi.org/
-
Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis : results of a Delphi surveyIn: European Respiratory Journal (ERJ) Jg. 57 (2021) Nr. 4, S. 2004219Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The Role of Diverse Immune Cells in SarcoidosisIn: Frontiers in Immunology Jg. 12 (2021) 788502Online Volltext: dx.doi.org/ (Open Access)
-
The diagnosis and treatment of pulmonary fibrosisIn: Deutsches Ärzteblatt international Jg. 118 (2021) Nr. 9, S. 152 - 162Online Volltext: dx.doi.org/ (Open Access)
-
A Comparison of Existing Questionnaires for Identifying the Causes of Interstitial and Rare Lung DiseasesIn: Respiration: International Journal of Thoracic Medicine Jg. 99 (2020) Nr. 2, S. 119 - 124Online Volltext: dx.doi.org/
-
Azathioprine for Connective Tissue Disease-Associated Interstitial Lung DiseaseIn: Respiration: International Journal of Thoracic Medicine Jg. 99 (2020) Nr. 8, S. 628 - 636Online Volltext: dx.doi.org/
-
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosisIn: European Respiratory Review (ERR) Jg. 29 (2020) Nr. 155, 190146Online Volltext: dx.doi.org/ (Open Access)
-
Hypersensitivity pneumonitisIn: Nature Reviews Disease Primers Jg. 6 (2020) Nr. 1, S. 65Online Volltext: dx.doi.org/
-
Nachruf Prof. Dr. Dr. Claus KroegelIn: Pneumologie Jg. 74 (2020) Nr. 10, S. 695 - 696Online Volltext: dx.doi.org/
-
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE) : A phase 2, randomised, double-blind, placebo-controlled trialIn: The Lancet Respiratory Medicine Jg. 8 (2020) Nr. 1, S. 25 - 33Online Volltext: dx.doi.org/
-
Progressive fibrosing interstitial lung disease : clinical uncertainties, consensus recommendations, and research prioritiesIn: The Lancet Respiratory Medicine Jg. 8 (2020) Nr. 9, S. 925 - 934Online Volltext: dx.doi.org/ (Open Access)
-
S2K-Leitlinie zur Diagnostik der idiopathischen LungenfibroseIn: Pneumologie Jg. 74 (2020) Nr. 5, S. 263 - 293Online Volltext: dx.doi.org/
-
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease : Data from the SENSCIS trialIn: Annals of the Rheumatic Diseases (ARD) Jg. 79 (2020) Nr. 11, S. 1478 - 1484Online Volltext: dx.doi.org/ (Open Access)
-
Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: A prospective multicentre trialIn: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. 6, S. 1901520Online Volltext: dx.doi.org/ (Open Access)
-
Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis : German and Japanese Cohort StudyIn: Journal of Clinical Medicine (JCM) Jg. 8 (2019) Nr. 12, 2069Online Volltext: dx.doi.org/ (Open Access)
-
Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipientsIn: Transplant Immunology Jg. 52 (2019) S. 40 - 44Online Volltext: dx.doi.org/
-
Correction to: The burden of sarcoidosis symptoms from a patient perspectiveIn: Lung Jg. 197 (2019) Nr. 2, S. 163Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging patternIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. 5, Article-No: 1901144Online Volltext: dx.doi.org/ (Open Access)
-
Die Rolle der Luftschadstoffe für die Gesundheit : Eine Replik auf die Expertise der Internationalen Gesellschaft für Umweltepidemiologie (ISEE) und der European Respiratory Society (ERS)In: Pneumologie Jg. 73 (2019) Nr. 5, S. 274 - 287Online Volltext: dx.doi.org/ (Open Access)
-
Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosisIn: Respiratory Research Jg. 20 (2019) Nr. 1, S. 55Online Volltext: dx.doi.org/ (Open Access)
-
Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary FibrosisIn: Chest Jg. 155 (2019) Nr. 4, S. 712 - 719Online Volltext: dx.doi.org/ (Open Access)
-
Erratum zu: Differenzialdiagnose interstitieller Lungenerkrankungen – „Interstitial pneumonia with autoimmune features“ (IPAF)In: Der Pneumologe Jg. 16 (2019) Nr. 1, S. 39Online Volltext: dx.doi.org/ (Open Access)
-
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?In: European Respiratory Journal (ERJ) Jg. 53 (2019) Nr. 2, S. 1800994Online Volltext: dx.doi.org/ (Open Access)
-
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis : results from the open-label extension study, INPULSIS-ONIn: The Lancet Respiratory Medicine Jg. 7 (2019) Nr. 1, S. 60 - 68Online Volltext: dx.doi.org/
-
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairmentIn: Respiratory Medicine Jg. 153 (2019) S. 44 - 51Online Volltext: dx.doi.org/ (Open Access)
-
Quantitative lipidomics in pulmonary alveolar proteinosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 200 (2019) Nr. 7, S. 881 - 887Online Volltext: dx.doi.org/
-
The Burden of Sarcoidosis Symptoms from a Patient PerspectiveIn: Lung Jg. 197 (2019) Nr. 2, S. 155 - 161Online Volltext: dx.doi.org/ (Open Access)
-
Utility of Anti-DSF70 Antibodies to Predict Connective Tissue Disease in Patients Originally Presenting with Idiopathic Interstitial PneumoniaIn: Respiration: International Journal of Thoracic Medicine Jg. 98 (2019) Nr. 1, S. 29 - 37Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
An emerging frontier in the treatment of acute exacerbation of idiopathic pulmonary fibrosisIn: Respiratory Investigation Jg. 56 (2018) Nr. 2, S. 97 - 99Online Volltext: dx.doi.org/
-
Anti-Interleukin-5-Therapie und eosinophile Granulomatose mit Polyangiitis : Ein Aufbruch?In: Der Pneumologe Jg. 15 (2018) Nr. 3, S. 189 - 192Online Volltext: dx.doi.org/
-
Anti-acid therapy in idiopathic pulmonary fibrosis : insights from the INPULSIS® trialsIn: Respiratory Research Jg. 19 (2018) S. 167Online Volltext: dx.doi.org/ (Open Access)
-
Differenzialdiagnose interstitieller LungenerkrankungenIn: Der Pneumologe Jg. 15 (2018) Nr. 6, S. 413 - 418Online Volltext: dx.doi.org/
-
Effect of pirfenidone on exercise capacity and dyspnea in patients with idiopathic pulmonary fibrosis (IPF) and more advanced lung function impairmentIn: Chest Jg. 154 (2018) Nr. Suppl. 4, S. 432A - 433AOnline Volltext: dx.doi.org/
-
Eosinophile Granulomatose und Polyangiitis : Diagnostik und TherapieIn: Der Pneumologe Jg. 15 (2018) Nr. 5, S. 333 - 343Online Volltext: dx.doi.org/
-
Eosinophile Granulozyten : physiologische und pathophysiologische FunktionenIn: Der Pneumologe Jg. 15 (2018) Nr. 5, S. 299 - 308Online Volltext: dx.doi.org/
-
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis : Uncertainties and ControversiesIn: Respiration: International Journal of Thoracic Medicine Jg. 96 (2018) Nr. 6, S. 571 - 587Online Volltext: dx.doi.org/
-
German Guideline for Idiopathic Pulmonary Fibrosis : Update on Pharmacological Therapies 2017In: Pneumologie Jg. 72 (2018) Nr. 2, S. 155 - 168Online Volltext: dx.doi.org/ (Open Access)
-
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib : results from the TOMORROW trial and its open-label extensionIn: Thorax Jg. 73 (2018) Nr. 6, S. 581 - 583Online Volltext: dx.doi.org/ (Open Access)
-
Modified GAP stage as a predictor of acute exacerbation in idiopathic pulmonary fibrosisIn: European Respiratory Journal (ERJ) Jg. 52 (2018) Nr. Suppl. 62, S. PA2907Online Volltext: dx.doi.org/
-
Nailfold capillaroscopy findings in ILD patients : results from a single centre investigationIn: European Respiratory Journal (ERJ) Jg. 52 (2018) Nr. Suppl. 62, S. PA2951Online Volltext: dx.doi.org/
-
Patientenfragebogen zur Erfassung der Ursachen interstitieller und seltener Lungenerkrankungen - klinische Sektion der DGPIn: Pneumologie Jg. 72 (2018) Nr. 6, S. 446 - 457Online Volltext: dx.doi.org/
-
Patterns of discontinuation in patients with IPF treated with open-label nintedanib : data from INPULSIS-ONIn: European Respiratory Journal (ERJ) Jg. 52 (2018) Nr. Suppl. 62, S. PA4777Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Phenotypes of organ involvement in sarcoidosisIn: European Respiratory Journal (ERJ) Jg. 51 (2018) Nr. 1, S. 1700991Online Volltext: dx.doi.org/ (Open Access)
-
Serum YKL-40 in workers at an indium-tin oxide production facility - ReplyIn: Respirology Jg. 23 (2018) Nr. 3, S. 342Online Volltext: dx.doi.org/ (Open Access)
-
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary FibrosisIn: Respiration: International Journal of Thoracic Medicine Jg. 95 (2018) Nr. 5, S. 317 - 326Online Volltext: dx.doi.org/ (Open Access)
-
The European IPF Registry : Addressing challenges and characteristics of patients with Idiopathic Pulmonary FibrosisIn: European Respiratory Journal (ERJ) Jg. 52 (2018) Nr. Suppl. 62, S. PA2198Online Volltext: dx.doi.org/
-
The European IPF registry (eurIPFreg) : baseline characteristics and survival of patients with idiopathic pulmonary fibrosisIn: Respiratory Research Jg. 19 (2018) S. 141Online Volltext: dx.doi.org/ (Open Access)
-
An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)In: Respiration: International Journal of Thoracic Medicine Jg. 94 (2017) Nr. 5, S. 408 - 415Online Volltext: dx.doi.org/ (Open Access)
-
Annual rate of FVC decline in Patients with IPF treared with Pirfenidone : Pooled Analysis (Encore)In: Respirology Jg. 22 (2017) Nr. Suppl. 2, S. 79Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received PirfenidoneIn: Respiration: International Journal of Thoracic Medicine Jg. 93 (2017) Nr. 6, S. 415 - 423Online Volltext: dx.doi.org/ (Open Access)
-
Differential diagnosis of granulomatous lung disease : Clues and pitfallsIn: European Respiratory Review (ERR) Jg. 26 (2017) Nr. 145, 170012Online Volltext: dx.doi.org/ (Open Access)
-
Effect of continued Pirfenidone treatment following >= 15% decline in 6MWD in IPF Patients-Pooled Analysis (Encore)In: Respirology Jg. 22 (2017) Nr. Suppl. 2, S. 79Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Effect of pirfenidone on mortality : pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisIn: The Lancet Respiratory Medicine Jg. 5 (2017) Nr. 1, S. 33 - 41Online Volltext: dx.doi.org/
-
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosisIn: Thorax Jg. 72 (2017) Nr. 2, S. 148 - 153Online Volltext: dx.doi.org/ (Open Access)
-
Eosinophile Granulomatose und Polyangiitis (Churg-Strauss-Syndrom) : Pathogenetische und klinische Grundlagen, Diagnostik und BehandlungszugāngeIn: Arzneimitteltherapie (AMT) Jg. 35 (2017) Nr. 11, S. 413 - 426
-
Epidemiologie und klinisches Erscheinungsbild der SarkoidoseIn: Klinische Monatsblätter für Augenheilkunde Jg. 234 (2017) Nr. 6, S. 790 - 795Online Volltext: dx.doi.org/
-
Erfahrungen und unterstützende Hinweise zur Anwendung von Nintedanib bei Patienten mit idiopathischer LungenfibroseIn: Pneumologie Jg. 71 (2017) Nr. 9, S. 567 - 579Online Volltext: dx.doi.org/
-
FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosisIn: Respiratory Medicine Jg. 123 (2017) S. 105 - 109Online Volltext: dx.doi.org/
-
Helicobacter Pylori As A Risk Factor For Acute Exacerbation In Idiopathic Pulmonary FibrosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 195 (2017) S. A3468
-
Idiopathic pleuroparenchymal fibroelastosis (PPFE) : A case study of a rare entityIn: Revista Portuguesa de Pneumologia (English Edition) Jg. 23 (2017) Nr. 6, S. 352 - 355Online Volltext: dx.doi.org/ (Open Access)
-
M32 Effect of pirfenidone on all-cause mortality (acm) and forced vital capacity (fvc) in idiopathic pulmonary fibrosis (ipf) patients with low fvc and/or low dlco : analysis of pooled data from ascend and capacityIn: Thorax Jg. 72 (2017) Nr. Suppl. 3, A254Online Volltext: dx.doi.org/
-
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosisIn: European Respiratory Review (ERR) Jg. 26 (2017) Nr. 146, 170057Online Volltext: dx.doi.org/ (Open Access)
-
Potential Utility Of Anti Dfs70 Antibodies To Exclude Systemic Autoimmune Rheumatic Disease (sard) In Patients With Interstitial Lung Disease (ild)In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 195 (2017) S. A7129
-
Quartile Forced Vital Capacity Changes At 3, 6, 9, And 12 Months With Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis : A Pooled Phase Iii AnalysisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 195 (2017) S. A5395
-
Reply : Effect of Nintedanib in Patients with Idiopathic Pulmonary FibrosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 195 (2017) Nr. 9, S. 1275Online Volltext: dx.doi.org/
-
Reply [Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis ]In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 195 (2017) Nr. 9, S. 1275Online Volltext: dx.doi.org/
-
S2k-Leitlinie Idiopathische Lungenfibrose – Update zur medikamentösen Therapie 2017In: Pneumologie Jg. 71 (2017) Nr. 7, S. 460 - U140Online Volltext: dx.doi.org/
-
Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitisIn: European Respiratory Journal (ERJ) Jg. 49 (2017) Nr. 2,Online Volltext: dx.doi.org/
-
Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosisIn: Respirology Jg. 22 (2017) Nr. 7, S. 1371 - 1378Online Volltext: dx.doi.org/
-
Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Disease : Comparison between Biopsy from 1 Segment and Biopsy from 2 Segments-Diagnostic Yield and ComplicationsIn: Respiration: International Journal of Thoracic Medicine Jg. 93 (2017) Nr. 4, S. 285 - 292Online Volltext: dx.doi.org/ (Open Access)
-
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar ProteinosisIn: Chest Jg. 150 (2016) Nr. 1, S. 251 - 253Online Volltext: dx.doi.org/
-
A confusing case report of pulmonary langerhans cell histiocytosis and literature reviewIn: Open Medicine Jg. 11 (2016) Nr. 1, S. 178 - 182Online Volltext: dx.doi.org/ (Open Access)
-
An Important Step Forward, but Still a Way to GoIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 193 (2016) Nr. 3, S. 340 - 341
-
Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in RecapIn: Chest Jg. 150 (2016) Nr. 4 Suppl., S. 537AOnline Volltext: dx.doi.org/
-
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis : a pooled analysisIn: The Lancet Respiratory Medicine Jg. 4 (2016) Nr. 5, S. 381 - 389Online Volltext: dx.doi.org/ (Open Access)
-
Anti-acid treatment in patients with IPF : interpret results from post-hoc, subgroup, and exploratory analyses with great caution – Authors' replyIn: The Lancet Respiratory Medicine Jg. 4 (2016) Nr. 9, S. e48Online Volltext: dx.doi.org/
-
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary FibrosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 193 (2016) Nr. 7, S. 745 - 752Online Volltext: dx.doi.org/
-
Clinical Manifestations of Respiratory Bronchiolitis as an Incidental Finding in Surgical Lung Biopsies : A Retrospective Analysis of a Large Austrian RegistryIn: Respiration: International Journal of Thoracic Medicine Jg. 91 (2016) Nr. 1, S. 26 - 33Online Volltext: dx.doi.org/
-
Clinical Spectrum Time Course in Non Anti Jo-1 Positive Antisynthetase SyndromeIn: Annals of the Rheumatic Diseases (ARD) Jg. 75 (2016) Nr. Suppl. 2, S. 540 - 541Online Volltext: dx.doi.org/
-
Deutschsprachige Validierung des „Kingʼs Brief Interstitial Lung Disease (K-BILD)“ Lebensqualitätsfragebogens für interstitielle LungenerkrankungenIn: Pneumologie Jg. 70 (2016) Nr. 11, S. 742 - 746Online Volltext: dx.doi.org/
-
Effect Of Continued Treatment With Pirfenidone Following A >= 10% Relative Decline In Percent Predicted Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis (ipf)In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 193 (2016) S. A4995
-
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity : analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisIn: Thorax Jg. 71 (2016) Nr. 5, S. 429 - 435Online Volltext: dx.doi.org/
-
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung functionIn: European Respiratory Journal (ERJ) Jg. 48 (2016) Nr. 3, S. 843 - 851Online Volltext: dx.doi.org/
-
Erratum: 58-year old woman with primary biliary cirrhosis and crepitationsIn: Deutsche Medizinische Wochenschrift - DMW Jg. 141 (2016) Nr. 4, S. 241Online Volltext: dx.doi.org/
-
Fam13a Polymorphism As A Prognostic Factor In Patients With Idiopathic Pulmonary FibrosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 193 (2016) S. A4982
-
How to handle IPF – the new Portuguese consensus documentIn: Revista Portuguesa de Pneumologia (English Edition) Jg. 22 (2016) Nr. 2, S. 70 - 72Online Volltext: dx.doi.org/ (Open Access)
-
Interstitial pneumonia with autoimmune features : a critical appraisal of the new definitionIn: Current Opinion in Pulmonary Medicine Jg. 22 (2016) Nr. 5, S. 442 - 449Online Volltext: dx.doi.org/
-
Long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis : pooled analysis of 4 clinical trialsIn: Thorax Jg. 71 (2016) Nr. Suppl. 3, S. A175 - A176Online Volltext: dx.doi.org/
-
MFAP4 : A candidate biomarker for hepatic and pulmonary fibrosis?In: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 33 (2016) Nr. 1, S. 41 - 50
-
MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosisIn: Orphanet Journal of Rare Diseases Jg. 11 (2016) S. 48Online Volltext: dx.doi.org/ (Open Access)
-
Pirfenidone for idiopathic pulmonary fibrosis : analysis of pooled data from three multinational phase 3 trialsIn: European Respiratory Journal (ERJ) Jg. 47 (2016) Nr. 1, S. 243 - 253Online Volltext: dx.doi.org/ (Open Access)
-
Pulmonale AlveolarproteinoseIn: Der Pneumologe Jg. 13 (2016) Nr. 1, S. 4 - 12Online Volltext: dx.doi.org/
-
Pulmonary alveolar proteinosis : Another autoimmune disease associated with sarcoidosis?In: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 33 (2016) Nr. 1, S. 90 - 94
-
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis : integrated analysis of cumulative data from 5 clinical trialsIn: BMJ Open Respiratory Research Jg. 3 (2016) S. e000105Online Volltext: dx.doi.org/ (Open Access)
-
Sarcoidosis in America. Analysis Based on Health Care UseIn: Annals of the American Thoracic Society Jg. 13 (2016) Nr. 8, S. 1244 - 1252Online Volltext: dx.doi.org/
-
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis : methodological concernsIn: European Respiratory Journal (ERJ) Jg. 48 (2016) Nr. 5, S. 1524 - 1526Online Volltext: dx.doi.org/ (Open Access)
-
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosisIn: European Respiratory Journal (ERJ) Jg. 47 (2016) Nr. 6, S. 1776 - 1784Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Annual rate of fvc decline in various patient sub-groups with idiopathic pulmonary fibrosis treated with pirfenidone : pooled analysis from 3 pivotal studiesIn: Thorax Jg. 71 (2016) Nr. Suppl. 3, S. A57Online Volltext: dx.doi.org/
-
Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis (IPF) under pirfenidone treatmentIn: Thorax Jg. 71 (2016) Nr. Suppl. 3, S. A58Online Volltext: dx.doi.org/
-
Cumulative distribution of patients by change in FVC% predicted in the inpulsis® trials of NINTEDANIB in patients with idiopathic pulmonary fibrosisIn: Thorax Jg. 71 (2016) Nr. Suppl. 3, S. A59 - A59Online Volltext: dx.doi.org/
-
(100) - KL-6 Changes in Serum Can Be Predictive of Chronic Lung Allograft Dysfunction in Lung Transplant RecipientsIn: The Journal of Heart and Lung Transplantation Jg. 34 (2015) Nr. 4 Suppl., S. 46Online Volltext: dx.doi.org/
-
58-jährige Patientin mit primär biliärer Zirrhose und KnisterrasselnIn: Deutsche Medizinische Wochenschrift - DMW Jg. 140 (2015) Nr. 24, S. 1847Online Volltext: dx.doi.org/
-
Antiacid therapy and progression free survival in idiopathic pulmonary fibrosis (IPF)In: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. OA3478Online Volltext: dx.doi.org/
-
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis : a phase 2 trial of carlumabIn: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. 6, S. 1740 - 1750Online Volltext: dx.doi.org/ (Open Access)
-
Challenges in IPF diagnosis, current management and future perspectivesIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 32 (2015) Nr. 1S, S. 28 - 35
-
Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosisIn: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. OA3510Online Volltext: dx.doi.org/
-
Determination of a single nucleotide polymorphism (SNP) of the TNFalpha-R1 region (TNFRSF1A) in patients with lung sarcoidosis : Preliminary resultsIn: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. PA3321Online Volltext: dx.doi.org/
-
Detrimental effects of medically indicated oral anticoagulation on survival in idiopathic pulmonary fibrosis (IPF)In: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. OA3479Online Volltext: dx.doi.org/
-
Diagnosis of sarcoidosisIn: Clinical Reviews in Allergy and Immunology Jg. 49 (2015) Nr. 1, S. 54 - 62Online Volltext: dx.doi.org/
-
Different biopsy techniques for confirmation of sarcoidosis: The game for the best diagnostic yield is still openIn: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. PA3326Online Volltext: dx.doi.org/
-
Effect of Pirfenidone on All-Cause Mortality in Patients With Idiopathic Pulmonary Fibrosis (IPF) : Comparison of Pooled Analysis With Meta-analysis From the ASCEND and CAPACITY TrialsIn: Chest Jg. 148 (2015) Nr. 4, S. 363A - 363BOnline Volltext: dx.doi.org/
-
Effect of Pirfenidone on IPF-Related Mortality Outcome Measures in Patients With Idiopathic Pulmonary Fibrosis (IPF) : Pooled Data Analysis From the ASCEND and CAPACITY TrialsIn: Chest Jg. 148 (2015) Nr. 4, S. 391A - 391BOnline Volltext: dx.doi.org/
-
Effect of anti-acid medication on reduction in FVC decline with nintedanibIn: Respirology Jg. 20 (2015) Nr. S3, S. 84 - 84Online Volltext: dx.doi.org/
-
Effect of anti-acid medication on reduction in FVC decline with nintedanibIn: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. OA4502Online Volltext: dx.doi.org/
-
Effect of baseline FVC on lung function decline with nintedanib : Results from the inpulsis trialsIn: Respirology Jg. 20 (2015) Nr. S 2, S. 87 - 87Online Volltext: dx.doi.org/
-
Effect of continued treatment with pirfenidone following a clinically meaningful decline in percent predicted forced vital capacity in patients with idiopathic pulmonary fibrosis (IPF)In: Thorax Jg. 70 (2015) S. A62 - A63Online Volltext: dx.doi.org/
-
Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD)In: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. PA3054Online Volltext: dx.doi.org/
-
Efficacy and safety of nintedanib in patients with IPF beyond week 52 : Data from the Phase II TOMORROW trialIn: Thorax Jg. 70 (2015) S. A63 - A64Online Volltext: dx.doi.org/
-
Extracellular 20S proteasome in BAL and serum of patients with alveolar proteinosisIn: Immunobiology Jg. 220 (2015) Nr. 3, S. 382 - 388Online Volltext: dx.doi.org/
-
GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disordersIn: BMC Pulmonary Medicine Jg. 15 (2015) S. 87Online Volltext: dx.doi.org/ (Open Access)
-
Hypersensitivity Pneumonitis : A Comprehensive ReviewIn: Journal of Investigational Allergology and Clinical Immunology Jg. 25 (2015) Nr. 4, S. 237 - 250
-
Infliximab for chronic cutaneous sarcoidosis : a subset analysis from a double-blind randomized clinical trialIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 32 (2015) Nr. 4, S. 289 - 295
-
MUC 5 B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosisIn: Respirology Jg. 20 (2015) Nr. 3, S. 439 - 444Online Volltext: dx.doi.org/
-
Pirfenidone is efficacious in patients with idiopathic pulmonary fibrosis (IPF) with more preserved lung functionIn: Thorax Jg. 70 (2015) Nr. Suppl 3, S. A81 - A81Online Volltext: dx.doi.org/
-
Positionspapier zur Bedeutung der forcierten Vitalkapazität für Patienten mit idiopathischer Lungenfibrose (IPF)In: Pneumologie Jg. 69 (2015) Nr. 8, S. 455 - 458Online Volltext: dx.doi.org/
-
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) : Integrated analysis of cumulative data from 5 clinical trialsIn: Thorax Jg. 70 (2015) S. A80 - A81Online Volltext: dx.doi.org/
-
Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD)In: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. PA3803Online Volltext: dx.doi.org/
-
Sporadic idiopathic non-specific interstitial pneumonia in monozygotic twin sistersIn: European Respiratory Journal (ERJ) Jg. 46 (2015) Nr. Suppl. 59, S. PA3827Online Volltext: dx.doi.org/
-
The changing treatment landscape in idiopathic pulmonary fibrosisIn: European Respiratory Review (ERR) Jg. 24 (2015) Nr. 135, S. 65 - 68Online Volltext: dx.doi.org/
-
Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosisIn: Respiratory Medicine Jg. 109 (2015) Nr. 7, S. 914 - 922Online Volltext: dx.doi.org/ (Open Access)
-
6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosisIn: European Respiratory Journal (ERJ) Jg. 43 (2014) Nr. 5, S. 1421 - 1429Online Volltext: dx.doi.org/
-
A pilot study : a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumoniaIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 31 (2014) Nr. 4, S. 343 - 349
-
All-cause mortality rate in patients with idiopathic pulmonary fibrosis : Implications for the design and execution of clinical trialsIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 189 (2014) Nr. 7, S. 825 - 831Online Volltext: dx.doi.org/ (Open Access)
-
Alveolar and intraparenchymal proteasome in sarcoidosisIn: Respiratory Medicine Jg. 108 (2014) Nr. 10, S. 1534 - 1541Online Volltext: dx.doi.org/
-
Analysis of lung function and survival in RECAP : An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosisIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 31 (2014) Nr. 3, S. 198 - 205
-
Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosisIn: Respiratory Medicine Jg. 108 (2014) Nr. 7, S. 1031 - 1039Online Volltext: dx.doi.org/
-
Biomarkers in connective tissue disease-associated interstitial lung diseaseIn: Seminars in Respiratory and Critical Care Medicine Jg. 35 (2014) Nr. 2, S. 181 - 200Online Volltext: dx.doi.org/
-
Combination therapy : The future of management for idiopathic pulmonary fibrosis?In: The Lancet Respiratory Medicine Jg. 2 (2014) Nr. 11, S. 933 - 942Online Volltext: dx.doi.org/
-
Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosisIn: Respirology Jg. 19 (2014) Nr. 5, S. 740 - 747Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostik und Therapie der kardialen SarkoidoseIn: Pneumologie Jg. 68 (2014) Nr. 2, S. 124 - 132Online Volltext: dx.doi.org/
-
Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPDgene polymorphismsIn: BMC Medical Genetics Jg. 15 (2014) S. 4Online Volltext: dx.doi.org/ (Open Access)
-
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisIn: The New England Journal of Medicine Jg. 370 (2014) Nr. 22, S. 2071 - 2082Online Volltext: dx.doi.org/
-
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis : Results of two 52-week, phase III, randomized, placebo-controlled trials (INPULSIS (TM))In: Respirology Jg. 19 (2014) Nr. Suppl. 3, S. 28Online Volltext: dx.doi.org/
-
Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse EventsIn: Advances in Therapy Jg. 31 (2014) Nr. 5, S. 575 - 576Online Volltext: dx.doi.org/
-
Interstitial lung diseaseIn: European Respiratory Review (ERR) Jg. 23 (2014) Nr. 131, S. 40 - 54Online Volltext: dx.doi.org/ (Open Access)
-
Konsensuspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) und der Deutschen Gesellschaft für Kardiologie – Herz und Kreislaufforschung (DGK) zur Diagnostik und Therapie der kardialen SarkoidoseIn: Der Kardiologe Jg. 8 (2014) Nr. 1, S. 13 - 85Online Volltext: dx.doi.org/
-
Pirfenidone in Idiopathic Pulmonary Fibrosis : Expert Panel Discussion on the Management of Drug-Related Adverse EventsIn: Advances in Therapy Jg. 31 (2014) Nr. 4, S. 375 - 391Online Volltext: dx.doi.org/ (Open Access)
-
S12 Effect Of Baseline Fvc On Decline In Lung Function With Nintedanib : Results From The Inpulsis TrialsIn: Thorax Jg. 69 (2014) Nr. Suppl. 2, S. A9Online Volltext: dx.doi.org/
-
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosisIn: European Respiratory Journal (ERJ) Jg. 44 (2014) Nr. 5, S. 1296 - 1307Online Volltext: dx.doi.org/
-
Serum KL-6 Levels Are Associated With Long-Term Prognosis in Lung Transplant RecipientsIn: The Journal of Heart and Lung Transplantation Jg. 33 (2014) Nr. 4 Suppl., S. S190 - S191Online Volltext: dx.doi.org/
-
Smoking-related idiopathic interstitial pneumoniaIn: European Respiratory Journal (ERJ) Jg. 44 (2014) Nr. 3, S. 594 - 602Online Volltext: dx.doi.org/
-
The WASOG sarcoidosis organ assessment instrument : An update of a previous clinical toolIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 31 (2014) Nr. 1, S. 19 - 27
-
The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids : A retrospective analysis from a randomized clinical trialIn: Respiratory Medicine Jg. 108 (2014) Nr. 1, S. 189 - 194Online Volltext: dx.doi.org/
-
55-jährige Patientin mit progredienter Belastungsdyspnoe und radiologischen LungenveränderungenIn: Deutsche Medizinische Wochenschrift - DMW Jg. 138 (2013) Nr. 11, S. 535 - 536Online Volltext: dx.doi.org/
-
An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumoniasIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 188 (2013) Nr. 6, S. 733 - 748Online Volltext: dx.doi.org/
-
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseasesIn: Respiratory Medicine Jg. 107 (2013) Nr. 9, S. 1444 - 1452Online Volltext: dx.doi.org/
-
Die deutsche IPF-Leitlinie : national vs. internationalIn: Pneumologie Jg. 67 (2013) Nr. 2, S. 79 - 80Online Volltext: dx.doi.org/
-
EBUS-TBNA for the Diagnosis of Sarcoidosis : Is it the Only Game in Town?In: Journal of Bronchology & Interventional Pulmonology Jg. 20 (2013) Nr. 3, S. 195 - 197Online Volltext: dx.doi.org/
-
Ethnic difference and serum KL-6 as predictors for acute exacerbation of idiopathic pulmonary fibrosisIn: Respirology Jg. 18 (2013) Nr. Suppl. 4, S. 58Online Volltext: dx.doi.org/
-
Idiopathic pulmonary fibrosis in 2011 : Key updates on guidelines and therapeutics. Concluding remarksIn: Respiratory Research Jg. 14 (2013) Nr. Suppl. 1, S. 8Online Volltext: dx.doi.org/
-
Idiopathic pulmonary fibrosis in 2011 : key updates on guidelines and therapeuticsIn: Respiratory Research Jg. 14 (2013) Nr. Suppl. 1,Online Volltext: dx.doi.org/
-
Interstitielle Lungenerkrankungen : Fortschritte in den letzten 10 Jahren und Perspektiven für die weitere EntwicklungIn: Der Pneumologe Jg. 10 (2013) Nr. Suppl. 1, S. 47 - 52Online Volltext: dx.doi.org/
-
Klinische Erfahrungen mit Pirfenidon in der Therapie der idiopathischen LungenfibroseIn: Deutsche Medizinische Wochenschrift: DMW Jg. 138 (2013) Nr. 11, S. 518 - 523Online Volltext: dx.doi.org/
-
Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumoniaIn: Immunobiology Jg. 218 (2013) Nr. 6, S. 930 - 937Online Volltext: dx.doi.org/
-
Om Prakash Sharma, MD, FRCP, FCCP - 4 July 1936 - 19 August 2012 : Internationally acclaimed specialist in sarcoidosisIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 30 (2013) Nr. 3, S. 166
-
S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen LungenfibroseIn: Pneumologie Jg. 67 (2013) Nr. 2, S. 81 - 111Online Volltext: dx.doi.org/
-
Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosisIn: Orphanet Journal of Rare Diseases Jg. 8 (2013) Nr. 1, S. 53Online Volltext: dx.doi.org/ (Open Access)
-
Treatment of idiopathic pulmonary fibrosis with ambrisentan : a parallel, randomized trialIn: Annals of Internal Medicine Jg. 158 (2013) Nr. 9, S. 641 - 649Online Volltext: dx.doi.org/
-
An Official American Thoracic Society Clinical Practice Guideline : The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung DiseaseIn: Critical Care Medicine Jg. 185 (2012) Nr. 9, S. 1004 - 1014Online Volltext: dx.doi.org/
-
Assays for laboratory confirmation of novel human coronavirus (HCOV-EMC) infectionsIn: Eurosurveillance Jg. 17 (2012) Nr. 49, S. 2 - 10Online Volltext: dx.doi.org/ (Open Access)
-
Chronic Hypersensitivity PneumonitisIn: Clinics in Chest Medicine Jg. 33 (2012) Nr. 1, S. 151 - 163Online Volltext: dx.doi.org/
-
Diagnostic approach to interstitial pneumonias in a single centre : report on 88 casesIn: Diagnostic Pathology Jg. 7 (2012) S. 160Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levelsIn: Respiratory Medicine Jg. 106 (2012) Nr. 12, S. 1756 - 1764Online Volltext: dx.doi.org/
-
Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndromeIn: Mediators of Inflammation (2012) 204250Online Volltext: dx.doi.org/ (Open Access)
-
Hypersensitivity PneumonitisIn: Immunology and Allergy Clinics of North America Jg. 32 (2012) Nr. 4, S. 537 - 556Online Volltext: dx.doi.org/
-
KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndromeIn: Orphanet Journal of Rare Diseases Jg. 7 (2012) Nr. 1, S. 99Online Volltext: dx.doi.org/ (Open Access)
-
Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacteriumIn: Modern Pathology Jg. 25 (2012) Nr. 9, S. 1284 - 1297Online Volltext: dx.doi.org/ (Open Access)
-
Prof. Om Prakash Sharma, 1936-2012In: European Respiratory Journal (ERJ) Jg. 40 (2012) Nr. 5, S. 1078 - 1080Online Volltext: dx.doi.org/
-
The European Respiratory Society spirometry tent : a unique form of screening for airway obstructionIn: European Respiratory Journal (ERJ) Jg. 39 (2012) Nr. 6, S. 1458 - 1467Online Volltext: dx.doi.org/ (Open Access)
-
Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosisIn: European Respiratory Journal (ERJ) Jg. 40 (2012) Nr. 6, S. 1468 - 1474Online Volltext: dx.doi.org/
-
An Official ATS/ERS/JRS/ALAT Statement : Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 183 (2011) Nr. 6, S. 788 - 824Online Volltext: dx.doi.org/
-
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 184 (2011) Nr. 4, S. 459 - 466Online Volltext: dx.doi.org/
-
Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantationIn: The Journal of Heart and Lung Transplantation Jg. 30 (2011) Nr. 12, S. 1374 - 1380Online Volltext: dx.doi.org/
-
Defining the clinical outcome status (COS) in sarcoidosis : Results of WASOG Task ForceIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 28 (2011) Nr. 1, S. 56 - 64
-
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosisIn: The New England Journal of Medicine Jg. 365 (2011) Nr. 12, S. 1079 - 1087Online Volltext: dx.doi.org/
-
Emerging potential treatments : New hope for idiopathic pulmonary fibrosis patients?In: European Respiratory Review (ERR) Jg. 20 (2011) Nr. 121, S. 201 - 207Online Volltext: dx.doi.org/
-
Forced vital capacity in patients with idiopathic pulmonary fibrosis : test properties and minimal clinically important differenceIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 184 (2011) Nr. 12, S. 1382 - 1389Online Volltext: dx.doi.org/
-
Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumoniaIn: Respiratory Medicine Jg. 105 (2011) Nr. 2, S. 292 - 297Online Volltext: dx.doi.org/ (Open Access)
-
Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosisIn: Clinical and Vaccine Immunology Jg. 18 (2011) Nr. 6, S. 931 - 939Online Volltext: dx.doi.org/ (Open Access)
-
Lungensarkoidose : Diagnostik und TherapieIn: Gynäkologische Praxis Jg. 35 (2011) Nr. 3, S. 473 - 482
-
Lungensarkoidose : Diagnostik und TherapieIn: Tägliche Praxis Jg. 52 (2011) Nr. 3, S. 463 - 472
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY) : two randomised trialsIn: The Lancet Jg. 377 (2011) S. 1760 - 1769Online Volltext: dx.doi.org/
-
Pulmonary alveolar proteinosis : New insights from a single-center cohort of 70 patientsIn: Respiratory Medicine Jg. 105 (2011) Nr. 12, S. 1908 - 1916Online Volltext: dx.doi.org/
-
Six-minute-walk test in idiopathic pulmonary fibrosis : Test validation and minimal clinically important differenceIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 183 (2011) Nr. 9, S. 1231 - 1237Online Volltext: dx.doi.org/
-
Stellungnahme der DGP zur Pressemitteilung des National Heart, Lung, and Blood Institute zur PANTHER-Studie bei IPF-Patienten vom 21.10. 2011In: Pneumologie Jg. 65 (2011) Nr. 12, S. 724 - 725Online Volltext: dx.doi.org/
-
Surfactant protein D and KL-6 serum levels in systemic sclerosis: Correlation with lung and systemic involvementIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 28 (2011) Nr. 1, S. 27 - 33
-
Treatment of pulmonary fibrosis : New substances and new interventionsIn: Der Internist Jg. 52 (2011) Nr. 12, S. 1422 - 1428Online Volltext: dx.doi.org/
-
A female soccer player with recurrent haemoptysis and iron deficiency anaemia : idiopathic pulmonary haemosiderosis (IPH)-case report and literature reviewIn: BMJ Case Reports (2010)Online Volltext: dx.doi.org/
-
Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung diseaseIn: Respiration: International Journal of Thoracic Medicine Jg. 80 (2010) Nr. 5, S. 372 - 378Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic modalities in sarcoidosis: BAL, EBUS, and PETIn: Seminars in Respiratory and Critical Care Medicine Jg. 31 (2010) Nr. 4, S. 404 - 408Online Volltext: dx.doi.org/
-
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosisIn: The European Respiratory Journal Jg. 35 (2010) Nr. 1, S. 14 - 26Online Volltext: dx.doi.org/ (Open Access)
-
Interstitielle Lungenerkrankungen – historische Entwicklung, Status quo und AusblickIn: Pneumologie Jg. 64 (2010) Nr. 9, S. 573 - 576Online Volltext: dx.doi.org/
-
SarcoidosisIn: Seminars in Respiratory and Critical Care Medicine Jg. 31 (2010) Nr. 4, S. 373 - 374Online Volltext: dx.doi.org/
-
The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platformIn: Lymphatic Research and Biology Jg. 8 (2010) Nr. 1, S. 81 - 87Online Volltext: dx.doi.org/
-
Alveolar extracellular 20s proteasome in patients with acute respiratory distress syndromeIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 179 (2009) Nr. 12, S. 1098 - 1106Online Volltext: dx.doi.org/
-
CD4⁺CD25⁺ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosisIn: Nephrology Dialysis Transplantation (NDT) Jg. 24 (2009) Nr. 1, S. 161 - 171Online Volltext: dx.doi.org/ (Open Access)
-
Esophageal sarcoidosis presenting as pseudodiverticulumIn: Sarcoidosis, Vasculitis and Diffuse Lung Diseases Jg. 25 (2008) Nr. 1, S. 64 - 67
-
Hepatopulmonales SyndromIn: Medizinische Klinik Jg. 94 (1999) Nr. 9, S. 505 - 512Online Volltext: dx.doi.org/
-
Interstitielle LungenerkrankungenIn: Zeitschrift für Pneumologie Jg. 20 (2023) Nr. 6, S. 297 - 299Online Volltext: dx.doi.org/ (Open Access)
-
Der Pneumologe wird zur Zeitschrift für Pneumologie : Zur Titeländerung Ihrer ZeitschriftIn: Zeitschrift für Pneumologie Jg. 19 (2022) Nr. 4, S. 187 - 188Online Volltext: dx.doi.org/ (Open Access)
-
Thorakale BildgebungIn: Zeitschrift für Pneumologie Jg. 19 (2022) Nr. 5, S. 247 - 248Online Volltext: dx.doi.org/
-
Idiopathische LungenfibroseIn: Der Pneumologe Jg. 17 (2020) Nr. 3, S. 151 - 152Online Volltext: dx.doi.org/ (Open Access)
-
The perpetual enigma of bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis : Is it of diagnostic value?In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. 2, S. 2001534Online Volltext: dx.doi.org/ (Open Access)
-
When the Game Changes : Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 PandemicIn: Chest Jg. 158 (2020) Nr. 3, S. 892 - 895Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Guest editorsIn: Idiopathic pulmonary fibrosis / Costabel, Ulrich; Crestani, Bruno; Wells, Athol U. (Hrsg.) (2016) S. VII - IX
-
IntroductionIn: Idiopathic pulmonary fibrosis / Costabel, Ulrich; Crestani, Bruno; Wells, Athol U. (Hrsg.) (2016) S. X - XIOnline Volltext: dx.doi.org/
-
Seltene LungenkrankheitenIn: Der Pneumologe Jg. 13 (2016) Nr. 1, S. 1 - 3Online Volltext: dx.doi.org/
-
Pneumologie im Wandel : eine StandortbestimmungIn: Deutsche Medizinische Wochenschrift - DMW Jg. 138 (2013) Nr. 11, S. 517Online Volltext: dx.doi.org/
-
Hot of the breath : Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the goodIn: Thorax Jg. 67 (2012) Nr. 11, S. 938 - 940Online Volltext: dx.doi.org/
-
Idiopathic pulmonary fibrosis : recent milestones in disease managementIn: European Respiratory Review (ERR) Jg. 21 (2012) Nr. 124, S. 140Online Volltext: dx.doi.org/ (Open Access)
-
Triple therapy in idiopathic pulmonary fibrosis : an alarming press releaseIn: European Respiratory Journal (ERJ) Jg. 39 (2012) Nr. 4, S. 805 - 806Online Volltext: dx.doi.org/
-
Pulmonary alveolar proteinosis associated with dust inhalation : Not secondary but autoimmune?In: American Journal of Respiratory and Critical Care Medicine Jg. 181 (2010) Nr. 5, S. 427 - 428Online Volltext: dx.doi.org/
-
Die Etablierung einer durchflusszytometrischen Multiparameter-Analyse der BAL und ihre Validierung durch Korrelation mit den Befunden der lichtmikroskopischen Routinediagnostik
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S85 - S86Online Volltext: dx.doi.org/ -
Progrediente Pulmonale Fibrose (PPF) bei Patienten mit exogen allergischer Alveolitis
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S102Online Volltext: dx.doi.org/ -
COVID-19 in patients with Pulmonary Alveolar Proteinosis : A European multicenter study
ERS International Congress 2022 ; 4-6 September 2022, Barcelona, Spain and online,In: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. Supplement 66,Online Volltext: dx.doi.org/ -
Comparison of a new Punch Needle with a conventional 22-gauge Needle in EBUS-TBNA in Patients with suspected Sarcoidosis
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S44Online Volltext: dx.doi.org/ -
Comparison of a 22G crown-cut needle with a conventional 22G needle with EBUS guidance in diagnosis of sarcoidosisIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, PA2454Online Volltext: dx.doi.org/
-
Histological confidence of transbronchial cryobiopsy in interstitial lung diseases is influenced by sample sizeIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, OA233Online Volltext: dx.doi.org/
-
Prevalence and quantification of thoracic pain (TP) through quantitative sensory testing (QST) in patients with chronic interstitial lung disease (cILD)In: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, PA2343Online Volltext: dx.doi.org/
-
Results of a phase 2 study of GLPG1205 for idiopathic pulmonary fibrosis (PINTA)In: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, RCT2904Online Volltext: dx.doi.org/
-
Association between weight loss and decline in FVC in patients with IPF
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28.03.2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S100 - S101Online Volltext: dx.doi.org/ -
Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP)
ERS Virtual Congress 2020,In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/ -
Cytokines, chemokines and growth factors concentration in BAL fluid from patients with idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28.03.2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S90 - S91Online Volltext: dx.doi.org/ -
Disease Progression Events in Trials of Nintedanib in Patients with Idiopathic Pulmonary FibrosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 201 (2020) S. A4548Online Volltext: dx.doi.org/
-
Klinische Nutzbarkeit eines mit Serum KL-6 modifizierten GAP-Indexes bei Patienten mit interstitiellen Lungenerkrankungen (ILD)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28.03.2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S10Online Volltext: dx.doi.org/ -
Nintedanib dose adjustments and adverse events in patients with progressive autoimmune disease-related interstitial lung diseases in the inbuild trialIn: Annals of the Rheumatic Diseases (ARD) Jg. 79 (2020) Nr. Suppl. 1, S. 1015Online Volltext: dx.doi.org/ (Open Access)
-
Potential Clinical Utility of Serum KL-6 for Improving the GAP-Staging in Patients with Interstitial Lung Diseases (ILD)
ATS 2020 International Conference, 15.-20. Mai 2020, Philadelphia, USA - abgesagt,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 201 (2020) S. A4037Online Volltext: dx.doi.org/ -
Safety and Tolerability of Nintedanib in Patients with Fibrosing ILDs : a Comparison of the INBUILD and INPULSIS Trials
ATS 2020 International Conference, 15.-20. Mai 2020, Philadelphia, USA - abgesagt,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 201 (2020) S. A1506Online Volltext: dx.doi.org/ -
The Gender-Age-Physiology (GAP) Index enhanced with KL-6 serum level for predicting disease progression in interstitial lung diseases (ILD)
ERS International Congress 2020,In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/ -
A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseasesIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. PA4728Online Volltext: dx.doi.org/
-
Potential Clinical Utility of MUC5B and TOLLIP Single Nucleotide Polymorphisms (SNP) in the Management of Patients with IPF : Preliminary Results
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,In: Pneumologie Jg. 73 (2019) Nr. 02, S. 113Online Volltext: dx.doi.org/ -
Potential clinical utility of MUC5B and TOLLIP single nucleotide polymorphisms (SNP) in in the management of patients with IPFIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. PA5370Online Volltext: dx.doi.org/
-
Safety and pharmacokinetics of nintedanib plus sildenafil in the INSTAGE trialIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. PA1354Online Volltext: dx.doi.org/
-
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassayIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. PA4697Online Volltext: dx.doi.org/
-
Clinical Relevance of Antinuclear Antibodies (ANA) in Patients with Hypersensitivity Pneumonitis (HP) : A Single Centre Experience
International Conference of the American Thoracic Society 2018 ; ATS 2018 ; May 18-23, 2018. San Diego,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 197 (2018) Nr. 9, abstract issue, S. A3019 -
Multiple progression events in patients with idiopathic pulmonary fibrosis (IPF)
Annual Scientific Meeting of the Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) ; 23–27 March 2018, Adelaide,In: Respirology Jg. 23 (2018) Nr. Suppl. 1, S. 102Online Volltext: dx.doi.org/ (Open Access) -
The RIFF Study (Cohort B) : A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab in Combination with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
International Conference of the American Thoracic Society 2018 ; ATS 2018 ; May 18-23, 2018, San Diego,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 197 (2018) Nr. 9, abstract issue, S. A6168 -
BAL findings in interstitial lung diseaseIn: Bronchoalveolar Lavage in Basic Research and Clinical Medicine / Schildgen, Oliver; Schildgen, Verena; Brockmann, Michael (Hrsg.) 2023, S. 66 - 93Online Volltext: dx.doi.org/
-
Definition and history of sarcoidosisIn: Sarcoidosis / Bonella, Francesco; Culver, Daniel A.; Israël-Biet, Dominique (Hrsg.) 2022, S. 1 - 7Online Volltext: dx.doi.org/
-
Idiopathic pulmonary fibrosisIn: ERS Monograph Lausanne Jg. 71 (2016) XI, 274 Seiten, Ill.
-
Progressive pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis (cHP) : a single center experience
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA2883Online Volltext: dx.doi.org/